Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Oral retinoid for CTCL introduced in Germany

June 26, 2002

BioVex commences phase I trial of OncoVEX GM-CSF for solid tumors

June 26, 2002

Novel antitumor naphthyridines identified by Dainippon

June 25, 2002

BioCryst describes PNP inhibitors with potential in cancer therapy

June 25, 2002

Bioenvision initiates clofarabine clinical program

June 25, 2002

PhotoCure subscribes for shares in Anticancer Therapeutic Inventions

June 25, 2002

CYP1B1 converts resveratrol to the antileukemic agent piceatannol

June 25, 2002

Possible mechanism by which vitamin E reduces the risk of prostate cancer

June 25, 2002

Tanox outlicenses Bak gene

June 21, 2002

MMP-targeting NeuGene antisense agent inhibits prostate cancer growth

June 21, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...